Skip to main content
. 2018 Jul 4;16(3):3439–3446. doi: 10.3892/ol.2018.9078

Table I.

In vitro inhibition of hepatocellular carcinoma tumor cell growth by different drug therapies.

IC50, µM

Cell line Sorafenib Docetaxel Doxorubicin Vinblastine 5-FU Erlotinib
LIXC-004NA 13.295 >20 0.675 <0.032 >200 13.998
LIXC-004SR 10.110 >20 >10 0.306 >200 >200

5-FU, fluorouracil; IC50, half-maximal inhibitory concentration.